ANIP: ANI Pharmaceuticals, Inc. - Summary | Jitta

ANI Pharmaceuticals, Inc.

NASDAQ:ANIP

Price
$79.45
Loss Chance
44.7%
4.91JITTA SCORE
50.34%Under Jitta Line
Jitta Ranking
30 / 719
318 / 4,228
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (70)
Recent Business Performance (73)
Financial Strength (63)
Return to Shareholders (25)
Competitive Advantage (69)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Revenue and EarningEarning loss detected in 2022
Operating MarginInconsistent
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
4.91
50.34%
3.14
94.26%
3.07
427.75%
Pharmaceuticals
5.04
76.39%
5.32
90.39%
4.55
18.49%
COMPANY DESCRIPTION
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.